Coagulation & dissolution of a blood clot Flashcards
Steps to blood clotting (general)
Vasoconstriction, platelet aggregation, clot strengthening, and clot dissolution
Normal hemostasis for coagulation is
a balance between generation of hemostatic clots and uncontrolled thrombus formation
The extrinsic pathway is
plasma mediated, initiation of hemostasis
AKA: primary hemostasis
key: tissue factor
The intrinsic pathway
amplifies and propagates hemostasis
AKA- secondary hemostasis
Key: thrombin
The common pathway results
in an insoluble fibrin clot
Preoperative coagulation testing should be based on
patient’s history and planned surgery
patient’s history is why you should check lab values
Agents that impact the coagulation cascade include
antiplatelets, anticoagulants, thrombolytics, procoagulants
There are more than ____ substances that affect blood coagulation
50
At normal homeostasis, _____ predominates but when a vessel is ruptured, _______ are activated
anticoagulants; procoagulants
Fibrinolysis is
the orderly breakdown of a stable blood clot
Hemostasis is regulated by interactions between
the blood vessel walls, circulating platelets, and clotting proteins in the plasma
Normally, vascular endothelium provides a
non-thrombogenic surface- antiplatelet or profibrinolytic surface
Damage to the endothelium exposes
the underlying extracellular matrix and elicits a contraction (vasoconstriction)
Thrombin, hypoxia, and high fluid sheer stress can
also induce prothrombotic endothelial changes
When platelets are exposed to the extracellular matrix in damaged endothelium they undergo
a series of biochemical and physical alterations
adhesion, activation, and aggregation
Normal concentration of platelets is
150,000-400,000 per microliter
spontaneous bleeding <50,000 micrograms/L
Lethal <10,000 micrograms/L
The life of a platelet is
8-12 days
Platelets are formed in
the bone marrow
A thrombocyte is a
thrombus/clot+ cells
Platelet adhesion occurs due to
exposure to subendothelial matrix proteins allows platelets to undergo a conformational change to adhere to the vascular wall
Von willebrand factor is produced in the
endothelium and platelets
vWF is released by
endothelial cells and by activated plateletes
vWF’s primary function is to
bind other proteins
it is particularly important as a bridging molecule between the subendothelial matrix and platelets forming a cross links
glycoprotein IIb/IIIa; glycoprotein Ib/factor IX/factor V receptor complex
The GPIb-V-IX complex binds
von Willebrand factor, allowing platelet adhesion and platelet plug formation at sites of vascular injury
Absence of GP1b-V-IV receptor is known as
Bernard Soulier syndrome
Von Willebrand factors is mainly activated in conditions of
high blood flow and shear stress
Deficiency of vWF shows primarily in
organs with small vessels such as skin, GI, and uterus
Von willebrands disease is diagnosed by
measuring the amount of vWF in a vWF antigen assay and the functionality of vWF with binding assays
factor VIII is also measured
Type 1 vWD is a
failure to secrete vWF into circulation or vWF being cleared more quickly than normal; mild, often undiagnosed until bleeding following surgery, easy bruising, or menorrhagia
Type 2 vWD is a
qualitative defect and bleeding varies- decreased ability to bind to GPib
decreased ability to bind to VIII
Type 3 vWD is
most severe, homozygous defective gene, complete absence of production of vWF
leads to extremely low levels of VIII since it does not exist to protect VIII from proteolytic degradation
Platelet type Von Willebrand disease is
a defect of the platelet’s GPIb receptor
vWF is normal, the platelet receptor GPIb is abnormal
We need to figure out which type of Von Willebrand’s disease they have in order to
know how to treat them
What medications are GPIIb/IIIa inhibitors?
considered a class of antiplatelets; includes abciximab, integrilin, and aggrastat